Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

VEGFR-3, VEGF-C and VEGF-D mRNA Quantification by RT-PCR in Different Human Cell Types

DANY LECLERS, KARINE DURAND, JEANNE COOK-MOREAU, HÉLÈNE RABINOVITCH-CHABLE, FRANCK G. STURTZ and MICHEL RIGAUD
Anticancer Research May 2006, 26 (3A) 1885-1891;
DANY LECLERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KARINE DURAND
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: karine.faucher{at}unilim.fr
JEANNE COOK-MOREAU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HÉLÈNE RABINOVITCH-CHABLE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANCK G. STURTZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHEL RIGAUD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The molecular events favoring lymphangiogenic pathways for tumor growth and dissemination are not perfectly understood, nor are the expression patterns of lymphangiogenic biomarkers such as the VEGFR-3 receptor and its ligands, VEGF-C and VEGF-D. In particular, VEGFR-3 expression is not restricted to the lymphatic endothelium, but is found on some cancer cells and other cell types. A quantitative RT-PCR method was set up to measure the mRNA levels of VEGFR-3, VEGF-C and VEGF-D. With this method, a very low detection threshold was obtained when tested on 17 different human cell types. It was found that, in contrast to VEGF-D mRNA, the VEGFR-3 and VEGF-C mRNAs were not expressed in all the cell types studied, and that blood cells expressed high VEGFR-3 mRNA levels compared to solid tumor cells. As a result, quantitative RT-PCR is considered to be a highly reliable and reproducible technique that could help elucidate lymphangiogenic marker patterns of expression and function in cancer.

  • Lymphangiogenesis
  • VEGFR-3
  • VEGF-C
  • VEGF-D
  • mRNA quantification

Footnotes

  • Received February 27, 2006.
  • Accepted March 20, 2006.
  • Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 3A
May-June 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
VEGFR-3, VEGF-C and VEGF-D mRNA Quantification by RT-PCR in Different Human Cell Types
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
VEGFR-3, VEGF-C and VEGF-D mRNA Quantification by RT-PCR in Different Human Cell Types
DANY LECLERS, KARINE DURAND, JEANNE COOK-MOREAU, HÉLÈNE RABINOVITCH-CHABLE, FRANCK G. STURTZ, MICHEL RIGAUD
Anticancer Research May 2006, 26 (3A) 1885-1891;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
VEGFR-3, VEGF-C and VEGF-D mRNA Quantification by RT-PCR in Different Human Cell Types
DANY LECLERS, KARINE DURAND, JEANNE COOK-MOREAU, HÉLÈNE RABINOVITCH-CHABLE, FRANCK G. STURTZ, MICHEL RIGAUD
Anticancer Research May 2006, 26 (3A) 1885-1891;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Silencing of β-TrCP2 Suppresses Growth and G1/S Cell Cycle Progression in Non-small Cell Lung Carcinoma Cells
  • Molecular Features of Gastrointestinal Stromal Tumors: A Single Referral Cancer Center Experience
  • Targeting AURKB Attenuates Tumor Growth in MYC-driven Lung Adenocarcinoma
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire